N-acetylcysteine in Psychiatric Disorders: Possible Role of Cysteinet Deregulation

Main Article Content

Marcos Arturo Martínez-Banaclocha

Abstract

In the last years, several clinical studies have shown the usefulness of N-acetylcysteine (NAC) in psychiatric diseases including a role in some drug abuse disorders. Although the glutathione replenishment and the antioxidant activity of NAC have been suggested as the principal mechanisms to improve such a wide range of conditions, these actions seem to be unspecific and insufficient to explain all reported effects. The present paper proposes that cysteinet (cysteine network) may be deregulated in psychiatric diseases explaining the wide-range beneficial actions of NAC supplementation.

 

Keywords:
N-acetylcysteine, cysteine, psychiatric diseases, psychosis, diabetes, cysteinet

Article Details

How to Cite
Arturo Martínez-Banaclocha, M. (2018). N-acetylcysteine in Psychiatric Disorders: Possible Role of Cysteinet Deregulation. International Neuropsychiatric Disease Journal, 12(1), 1-6. https://doi.org/10.9734/INDJ/2018/44483
Section
Minireview Article